Related Experiment Video
Updated: Jun 23, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Surgical ventricular restoration combined with mitral valve procedure for endstage ischemic cardiomyopathy
Hisayoshi Suma1, Hiroaki Tanabe, Tokuhisa Uejima
1The Cardiovascular Institute, 7-3-10 Roppongi, Minato-ku, Tokyo 106-0032, Japan. sumah@cvi.or.jp
Insights
Combined mitral and left ventricular reconstruction effectively treats advanced ischemic heart failure with dilated left ventricles and mitral regurgitation, improving survival and heart function.
Area of Science:
- Cardiovascular Surgery
- Heart Failure Management
- Cardiac Reconstruction
Background:
- Dilated left ventricle with mitral regurgitation signifies severe chronic ischemic heart failure.
- Optimal surgical strategies for these complex cases remain a focus of research.
Purpose of the Study:
- To evaluate the 7-year experience with combined mitral valve and left ventricular reconstruction.
- To assess the efficacy and outcomes of this combined approach in advanced heart failure patients.
Main Methods:
- Retrospective analysis of 76 patients with advanced heart failure due to dilated ischemic cardiomyopathy and mitral regurgitation.
- Procedures included mitral reconstruction (repair or replacement) and left ventriculoplasty (Dor, SAVE, PLV) combined with coronary artery bypass grafting (CABG).
Main Results:
- Operative mortality was 7.9%, with lower rates in elective cases.
- Significant improvements observed in ejection fraction (24.9% to 33.3%) and cardiac index (2.0 to 2.6 L/min/m²).
- Reduced ventricular volumes and improved NYHA class (3.5 to 1.4) in survivors; 5-year survival rate was 67.7%.
Conclusions:
- Combined mitral and left ventricular reconstruction is an effective treatment for end-stage ischemic cardiomyopathy.
- The procedure significantly improves cardiac function and clinical status in patients with dilated left ventricle and mitral regurgitation.
Objective:
A poor functioning dilated left ventricle with mitral regurgitation is the worst condition in chronic ischemic heart failure. Our 7-year experience in combined mitral valve and left ventricular reconstruction was evaluated.
Materials And Methods:
Among 246 patients having undergone a left ventriculoplasty for postinfarction left ventricular dysfunction in our experience, there were 76 patients with advanced heart failure due to dilated ischemic cardiomyopathy with mitral regurgitation (70 males and 6 females with a mean age of 60 years). All patients had NYHA class III (n = 41) or IV (n = 35) heart failure, including 26 patients (34%) with inotropic support before the operation. All patients had a mitral regurgitation of more than 2+ and 46 patients (61%) had 3+ or more. Mitral reconstruction (61 repairs, 15 replacements) and left ventriculoplasty (Dor 34, SAVE 36, PLV 6) were undergone in combination with CABG (74%).
Results:
Operative mortality was 7.9% (5.0% in 60 elective and 18.8% in 16 emergency operations). The ejection fraction and cardiac index increased from 24.9 +/- 7.0% to 33.3 +/- 8.7%, and 2.0 +/- 0.4 l/min/m2 to 2.6 +/- 0.4 l/min/m2, respectively (p < 0.001). The endodiastolic and endosystolic volume indices, and diastolic dimension decreased from 165.9 +/- 43.2 ml/m2 to 121.2 +/- 31.1 ml/m2, 123.3 +/- 38.9 ml/m2 to 74.0 +/- 27.5 ml/m2, and 69.5 +/- 7.7 mm to 61.2 +/- 7.1 mm, respectively (p < 0.001). Late deaths were noted in 13 patients (17.1%), with 10 cardiac deaths. One- and 5-year survival rates were 80.2% and 67.7%, respectively. The mean NYHA class improved from 3.5 to 1.4 among the survivors. Multivariate analysis showed that patients with a mitral regurgitation of 3+ or more and preoperative endosystolic volume index were significant predictors for postoperative mortality. However, age, preoperative inotropes and pulmonary hypertension did not show any significant differences.
Conclusion:
Combined mitral and left ventricular reconstruction is effective in treating advanced heart failure with endstage ischemic cardiomyopathy associated with a dilated left ventricle and mitral regurgitation.
More Related Videos
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Mitral Stenosis III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Regurgitation III: Medical Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests

